Sign in
4

Changes in Ownership

DiaMedica Therapeutics Inc. Filed Acc 0001760123-26-000002

Options or other derivatives

  • President & CEO acquired 380,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pauls Dietrich John President & CEO 2026-06-01 Grant or award · Stock Option (right to buy) +380,000 380,000 D
Loading xslF345X06/form4-06032026_090640.xml…